InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.046

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Immuron CEO presentation to Emerging Growth Conference 26 Sep 2024 8:27AM $0.105 $0.046 fallen by 56.19%
$15 Immuron Plans Phase 2 Trial for IMM-529 following FDA review 5 Sep 2024 4:10PM $0.093 $0.046 fallen by 50.54%
$15 Appendix 4E and Preliminary Final Report 30 Aug 2024 9:56AM $0.095 $0.046 fallen by 51.58%
$15 Immuron CEO presentation to Peak Biotech Showcase 21 Aug 2024 8:57AM $0.100 $0.046 fallen by 54%
$15 New US DoD Research Award to develop enhanced Travelan 16 Aug 2024 8:52AM $0.096 $0.046 fallen by 52.08%
$15 Immuron CEO presentation to MarketOpen Direct Connect 8 Aug 2024 8:33AM $0.096 $0.046 fallen by 52.08%
$15 Immuron CEO to host webinar on MarketOpen Direct Connect 7 Aug 2024 9:46AM $0.098 $0.046 fallen by 53.06%
$15 Change in substantial holding 6 Aug 2024 8:18AM $0.100 $0.046 fallen by 54%
$15 Immuron CEO to present at TechKnow Invest Roadshow 31 Jul 2024 8:22AM $0.100 $0.046 fallen by 54%
$15 Immuron CEO to present at Emerging Growth Conference 18 Jul 2024 9:58AM $0.100 $0.046 fallen by 54%
$15 Notification of cessation of securities - IMC 16 Jul 2024 4:39PM $0.100 $0.046 fallen by 54%
$15 Immuron Travelan record sales globally, Australia and USA 15 Jul 2024 8:46AM $0.086 $0.046 fallen by 46.51%
$15 Immuron CEO Steven Lydeamore presentation to Sharewise 9 Jul 2024 9:08AM $0.083 $0.046 fallen by 44.58%
$15 Immuron CEO Steven Lydeamore to present at Sharewise 4 Jul 2024 8:27AM n/a $0.046 n/a
$15 Immuron lodges Form F-3 and ATM Prospectus with U.S. SEC 3 Jul 2024 9:13AM n/a $0.046 n/a
$15 IMM-529 pre-IND FDA filing 2 Jul 2024 8:57AM $0.083 $0.046 fallen by 44.58%
$15 Initial Director's Interest Notice JJ 5 Jun 2024 9:50AM $0.090 $0.046 fallen by 48.89%
$15 Final Director's Interest Notice RA 5 Jun 2024 9:49AM $0.090 $0.046 fallen by 48.89%
$15 Board Changes 31 May 2024 10:41AM $0.097 $0.046 fallen by 52.58%
$15 Immuron CEO Steven Lydeamore to present at Peak Sky High 31 May 2024 8:44AM $0.097 $0.046 fallen by 52.58%
$15 Notification of cessation of securities - IMC 24 May 2024 4:51PM $0.094 $0.046 fallen by 51.06%
$15 Final Director's Interest Notice (SA) 3 May 2024 2:26PM $0.100 $0.046 fallen by 54%
$15 Board Change 3 May 2024 10:02AM $0.099 $0.046 fallen by 53.54%
$15 Change in substantial holding 30 Apr 2024 8:23AM $0.100 $0.046 fallen by 54%
$15 Immuron CEO Steven Lydeamore to present at The Watchlist 23 Apr 2024 9:17AM $0.100 $0.046 fallen by 54%

151 - 175 of 782 results

Page 7 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.